Last reviewed · How we verify
Germinal peptide eye drops
At a glance
| Generic name | Germinal peptide eye drops |
|---|---|
| Also known as | shengfatai-eye drops, Germinal peptide |
| Sponsor | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect (PHASE1)
- The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study (PHASE1)
- Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects (PHASE2)
- Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |